EPISODE · Dec 11, 2025 · 23 MIN
Episode 33: Novartis
from PETRI DISH PERSPECTIVES · host Manead Khin
Send us Fan MailIn this episode of Petri Dish Perspectives, we dive deep into the remarkable evolution of Novartis, one of the world’s most influential and scientifically ambitious pharmaceutical companies. From its 18th-century dye-making origins to its modern dominance in gene therapy, oncology, and complex biologics, Novartis has become a case study in strategic reinvention.We explore the company’s defining breakthroughs from Gleevec, the drug that rewrote the playbook for targeted cancer therapies, to cutting-edge innovations like CAR-T, RNA therapeutics, radioligand therapy, and AI-driven drug design. You’ll learn how visionary leaders, bold pipeline bets, and a focus on precision medicine shaped Novartis into a global powerhouse.🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes every Thursday!https://linktr.ee/maneadkhin#Novartis #BiotechPodcast #DrugDiscovery #Gleevec #CAR_T #GeneTherapy #OncologyInnovation #PharmaStrategy #PetriDishPerspectives #HealthcareInnovation #PrecisionMedicine #LifeSciences #BiotechResearchSupport the show© 2026 The Perspective Bureau LLC. All rights reserved.
NOW PLAYING
Episode 33: Novartis
No transcript for this episode yet
Similar Episodes
May 14, 2026 ·26m
May 13, 2026 ·49m
May 12, 2026 ·35m
May 11, 2026 ·49m
May 7, 2026 ·48m
May 7, 2026 ·30m